Key Highlights:
- Cresco Labs (CRLBF, Financial) shares fell by 9% due to the delay in its Q1 2025 earnings report.
- Analysts maintain a price target of $3.00, indicating significant potential upside.
- The stock is rated "Outperform" by brokerage firms, with a promising future GF Value estimate.
Cresco Labs Earnings Announcement Delay
Cresco Labs Inc. (CRLBF) experienced a notable 9% drop in its stock price following the announcement of a delay in its Q1 2025 earnings report. The company attributed this postponement to the need for additional time to complete its financial statements accurately. A revised date for the earnings call will be provided shortly, with final filings anticipated by May 30, 2025.
Analyst Insights and Price Predictions
According to data from a single analyst, Cresco Labs (CRLBF, Financial) has a one-year average target price of $3.00. This target is consistent across high and low estimates, suggesting a remarkable potential upside of 293.06% from the current stock price of $0.76. Investors can explore more detailed estimates on the Cresco Labs Inc (CRLBF) Forecast page.
Brokerage Ratings and Market Sentiment
The consensus among eight brokerage firms positions Cresco Labs Inc. (CRLBF, Financial) with an average recommendation of 2.1, which corresponds to an "Outperform" rating. This rating is derived from a scale where 1 represents a "Strong Buy" and 5 signifies a "Sell," highlighting a generally positive outlook from analysts.
GF Value and Future Potential
Utilizing the GuruFocus methodology, the estimated GF Value for Cresco Labs Inc. (CRLBF, Financial) in one year is projected to be $1.41. This indicates a potential upside of 84.74% from the current trading price of $0.76325. The GF Value is a calculated estimation of the fair market value the stock should ideally trade at, based on historical multiples, previous business growth, and future performance projections. For more comprehensive insights, visit the Cresco Labs Inc (CRLBF) Summary page.
